Peptide record

TPDB08573

Antibacterial Antifungal Toxicity standard
17 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB08573
Antibacterial Antifungal Toxicity
Anti-infective peptides Toxicity and safety peptides
AntiBP3 dbAMP DRAMP Peptipedia Antifungipept CAFPdb
standard
No
A 17-aa standard natural multi-activity (Antibacterial, Antifungal, and Toxicity) peptide sequence curated from AntiBP3, dbAMP, DRAMP, and other sources, with an available 3D structural model.
Sequence
AWCFRVCYRGACYRRCR
Physicochemical Analysis
C93H141N33O20S4
NDEQHILKMPST
R
2169.59
9.73
5
0
7
+5
-2.03
-0.341
28.82
Mammalian: 4.4 hour Yeast: >20 hour E.coli: >10 hour
8730
402.38
6
Residue Composition
number
2
A
5
R
0
N
0
D
4
C
0
E
0
Q
1
G
0
H
0
I
0
L
0
K
0
M
1
F
0
P
0
S
0
T
1
W
2
Y
1
V
Amino Acid Distribution
A: 2 R: 5 N: 0 D: 0 C: 4 E: 0 Q: 0 G: 1 H: 0 I: 0 L: 0 K: 0 M: 0 F: 1 P: 0 S: 0 T: 0 W: 1 Y: 2 V: 1
Chemical Descriptors
17
C93H141N33O20S4
2169.59
9.73
+5
-2.03
-0.341
Evidence Records 3 records
Evidence 1 Activity

Activity

<=10% Hemolysis
Toxicity
0.2 µg/mL
Hemolytic Cytotoxic
<=10% Hemolysis | 0.2 | µg/mL | target cell: Human erythrocytes

Target

Human erythrocytes

Source & Reference

NA
DBAASP
Structure-Activity and -Toxicity Relationships of the Antimicrobial Peptide Tachyplesin-1. | ACS Infect Dis | 2017
Evidence 2 Activity

Activity

Toxicity
Cytotoxic
- | NA | target cell: Human embryonic kidney HEK293 cells

Target

Human embryonic kidney HEK293 cells

Source & Reference

NA
DBAASP
Structure-Activity and -Toxicity Relationships of the Antimicrobial Peptide Tachyplesin-1. | ACS Infect Dis | 2017
Evidence 3 Activity

Activity

Toxicity
Hemolytic Cytotoxic
Hemolytic_activity: [Ref.28960954] MHC10=0.2 µg/ml against human red blood cells | Cytotoxicity: [Ref.28960954] The peptide did not show cytotoxicity against HEK293 cells at the highest tested concentration, 100 µg/ml.

Target

erythrocytes

Source & Reference

NA
DRAMP
ACS Infect Dis. 2017 Dec 8 3(12):917-926. doi: 10.1021/acsinfecdis.7b00123.